Class I - Dangerous
Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
💊
Prescription Drugs
💊 Drugs • 12,141 recalls
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, Manufactured by: Gland Pharma Limited, Hyderabad, India, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 --- NDC 0409-1140-01
Hospira Inc., A Pfizer Company
Class I - Dangerous
Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg 30 tablets per bottle, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5720-56
Teva Pharmaceuticals USA
Class I - Dangerous
Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.
Class I - Dangerous
Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56
Teva Pharmaceuticals USA
Class I - Dangerous
Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Lack of Assurance of Sterility; media fill failure at manufacturer
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Class I - Dangerous
Lack of Assurance of Sterility; media fill failure at manufacturer
Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed by OMP, Inc., Long Beach, CA Made in USA, NDC 62032-222-02
Valeant Pharmaceuticals North America
Class I - Dangerous
Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.
Class I - Dangerous
Lack of Assurance of Sterility: Customer complaints for leaking bags.